Vanguard Group Inc Cardlytics, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Cardlytics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,668,815 shares of CDLX stock, worth $9.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,668,815
Previous 2,412,549
10.62%
Holding current value
$9.02 Million
Previous $19.8 Million
56.88%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CDLX
# of Institutions
129Shares Held
31MCall Options Held
1.23MPut Options Held
775K-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny6.42MShares$21.7 Million1.36% of portfolio
-
Black Rock Inc. New York, NY3.15MShares$10.7 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY2.23MShares$7.52 Million0.65% of portfolio
-
Kps Global Asset Management Uk LTD London, X01.22MShares$4.12 Million0.93% of portfolio
-
Worldly Partners Management, LLC Boston, MA1.16MShares$3.91 Million1.76% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $111M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...